Tuberculosis, Multidrug-ResistantTreatment OutcomeAntitubercular AgentsRetreatmentDrug Therapy, CombinationRetrospective StudiesTreatment FailureRibavirinRecurrenceInterferon-alphaFollow-Up StudiesPolyethylene GlycolsTuberculosis, PulmonaryProspective StudiesSalvage TherapyDrug Administration ScheduleTime FactorsAntiviral AgentsMycobacterium tuberculosisNeoplasm Recurrence, LocalHepatitis C, ChronicCombined Modality TherapyAntineoplastic AgentsAntineoplastic Combined Chemotherapy ProtocolsRemission InductionDisease-Free SurvivalRisk FactorsBrazilSurvival AnalysisSurvival RateNeoplasm StagingRecombinant ProteinsCohort StudiesSeverity of Illness IndexAntibodies, MonoclonalPrognosisQuestionnairesDose-Response Relationship, Drug